WO2003059305A1 - Procede et dispositif pour la prevention de la carie dentaire - Google Patents
Procede et dispositif pour la prevention de la carie dentaire Download PDFInfo
- Publication number
- WO2003059305A1 WO2003059305A1 PCT/US2002/000084 US0200084W WO03059305A1 WO 2003059305 A1 WO2003059305 A1 WO 2003059305A1 US 0200084 W US0200084 W US 0200084W WO 03059305 A1 WO03059305 A1 WO 03059305A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tooth
- fluoride
- laser
- treatment
- enamel
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 45
- 208000002925 dental caries Diseases 0.000 title claims abstract description 16
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims abstract description 101
- 230000001427 coherent effect Effects 0.000 claims abstract description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 52
- 238000011282 treatment Methods 0.000 claims description 46
- 229910052786 argon Inorganic materials 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000002324 mouth wash Substances 0.000 claims description 13
- 229940051866 mouthwash Drugs 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 12
- 150000002894 organic compounds Chemical class 0.000 claims description 10
- 239000013043 chemical agent Substances 0.000 claims description 8
- 230000001678 irradiating effect Effects 0.000 claims description 7
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 7
- 229960002799 stannous fluoride Drugs 0.000 claims description 7
- 230000005670 electromagnetic radiation Effects 0.000 claims description 6
- 239000011368 organic material Substances 0.000 claims description 6
- 239000011775 sodium fluoride Substances 0.000 claims description 6
- 235000013024 sodium fluoride Nutrition 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims 1
- 150000004673 fluoride salts Chemical group 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 21
- 230000008569 process Effects 0.000 abstract description 3
- 230000035515 penetration Effects 0.000 abstract description 2
- 210000003298 dental enamel Anatomy 0.000 description 46
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 18
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 18
- 238000013532 laser treatment Methods 0.000 description 16
- 239000013078 crystal Substances 0.000 description 15
- 239000011575 calcium Substances 0.000 description 8
- 238000005115 demineralization Methods 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000002328 demineralizing effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 230000008016 vaporization Effects 0.000 description 5
- 238000009834 vaporization Methods 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 238000002441 X-ray diffraction Methods 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 238000007545 Vickers hardness test Methods 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010016818 Fluorosis Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000004042 dental fluorosis Diseases 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000011418 maintenance treatment Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000003685 thermal hair damage Effects 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- HUSUHZRVLBSGBO-UHFFFAOYSA-L calcium;dihydrogen phosphate;hydroxide Chemical compound O.[Ca+2].OP([O-])([O-])=O HUSUHZRVLBSGBO-UHFFFAOYSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000004489 deciduous teeth Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 238000001941 electron spectroscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004334 fluoridation Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical group 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003232 mucoadhesive effect Effects 0.000 description 1
- 230000032724 odontogenesis Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000068 pit and fissure sealant Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000001521 two-tailed test Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C1/00—Dental machines for boring or cutting ; General features of dental machines or apparatus, e.g. hand-piece design
- A61C1/0046—Dental lasers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0606—Mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
Definitions
- This invention relates to a method and an apparatus for preventing tooth decay.
- the invention relates to using a visible light beam or electromagnetic radiation treatment and subsequent low concentration fluoride treatment to prevent tooth decay.
- Tooth decay is caused by demineralization of the tooth structure at either the enamel or root surface.
- the enamel is a thin layer (1-2 mm) composed of a crystal-type structure of hydroxyapatite or calcium phosphate hydroxide, containing large amounts of calcium and phosphorus.
- Dental enamel is a porous material and although it contains about 96% by weight of mineral, this is equivalent to approximately 85 percent by volume. The remaining 15 percent by volume is made up of water, protein and lipid, which form the diffusion channels though which acids and minerals can travel in or out of the tooth.
- the dentin, the major part of the core of the tooth is composed of CaCO 3 , a chalk-like material. Although it is 70% by weight of mineral, it also contains 20% by weight organic and 10% by weight water. This corresponds to 47% by volume mineral.
- Tooth decay, or dental caries results from the growth of bacteria on the tooth.
- the bacteria metabolize sugars to acid and this dissolves the tooth.
- the bacteria grow as a plaque on the tooth and treatment involves periodic removal of the plaque and strengthening of the tooth to make it more resistant to the acid produced by the bacteria.
- Other professional methods to prevent tooth decay have included fluoride, pit and fissure sealants, and varnishes. However, none of these methods individually protect all of the tooth surfaces nor are they permanent, usually lasting less than 5 years.
- heat treatment has been explored as an alternative method. By treating the tooth with a very high heat, from 250-1000°C, the structure of the tooth is changed, making it more resistant to acid. This method has never been used clinically because of safety concerns.
- the action of the laser, as well as other types of tooth treatments, to produce resistance of the tooth to acid can be envisioned as follows: it has been hypothesized that tooth enamel crystals ("hydroxyapatite") possess two types of sites from which dissolution can occur.
- the first type of site (the "thermal” site) is less resistant to dissolution by acids under conditions typically found in the oral environment than is the second type of site (the “thermal” site).
- the invention provides a composition for preventing tooth decay in a tooth treated with electromagnetic radiation having fluoride at a concentration of less than 45 ppm fluoride to (0.01%) to 0.002 ppm fluoride.
- the composition may be a mouthwash, a patch, or a toothpaste.
- the invention provides a method of treating a tooth by irradiating the tooth with a light beam, having wavelengths in the range of between from about 400nm to about 810nm, and irradiating by exposing the tooth to an energy and an energy density sufficient to vaporize organic material without damaging the tooth structure.
- a further embodiment involves bonding a chemical agent to the crystalline structures of the tooth after removal of the organic compound.
- the chemical agent is fluoride.
- the effective concentration of fluoride is less than or equal to 200 ppm of stannous fluoride (0.08%) or 1000 ppm of sodium fluoride (0.275%).
- the fluoride acts by binding to hydroxide groups within the hydroxyapatite crystal.
- the fluoride penetrates to the subsurface more than 0.1 microns.
- the light beam may be a coherent or incoherent light source.
- it is a laser, more preferably an argon laser.
- the wavelength of the laser is selected from the group consisting of: red, green, blue, and yellow lasers.
- a incoherent light source may be an LED, preferably having a wavelength from the IR spectra selected from the group consisting of green, blue, yellow, and red light.
- the argon laser beam is applied at 250mJ for 10 seconds for each treated surface.
- the tooth is treated for a period of time of more than 1 sec for each treated surface.
- the light beam has an energy density below about 65 J/cm , even more preferably, 30 J/cm and even more preferably, 12 J/cm .
- the treatment heats the tooth structure to a temperature less than about
- the treatment heats the tooth structure to a temperature less than about 100°C.
- the tooth structure which is being heated may specifically be localized sites containing concentrations of water and/or organic materials.
- the method includes treating with fluoridated mouthwash, toothpaste, or a patch after treatment.
- the mouthwash contains 45 ppm fluoride to (0.01%)) to 0.002 ppm fluoride.
- the fluoride is applied for 1 day to 80 years.
- a further embodiment is a method which reduces the a axis of a crystal of hydroxyapatite in a tooth from 9.45A to 9.43A by irradiating the tooth with a visible or near visible light beam, preferably having wavelengths in the range of between from about 400nm to about 810nm. Preferably at an energy density below about 65 J/cm 2 , even more
- the a axis is reduced at a temperature less than 250°C.
- a further embodiment is a method of treating a tooth by changing the phosphate/calcium ratio in a portion of a tooth by more than 10% using electromagnetic radiation, preferably having a wavelength between about 400nm to about 810nm.
- the electromagnetic radiation is of a wavelength which is substantially transmissible through water.
- the calcium phosphate ratio is changed at a temperature less than about 250°C.
- a further embodiment of the invention is a home treatment kit for the treatment of a tooth containing a fluoride mixture for application to the tooth, a light source which produces wavelengths in the range of between about 400nm to about 750 nm adapted to illuminate the fluoride mixture, and at least one of a fluoride mouthwash, and a fluoride patch.
- a further embodiment of the invention is a method of treating a tooth by irradiating the organic molecules within the tooth structure to reduce the solubility of the tooth to acid.
- the method is applied to the tooth enamel, dentin, or cementum.
- the treatment heats the tooth structure to a temperature less than about 250°C.
- the method results in a permanent or semi-permanent change to the solubility of the tooth.
- a further embodiment of the invention is a method of treating a tooth, by changing the structure and composition of a tooth to include P 2 O 7 as measured by x-ray diffraction by irradiating said tooth with a visible or near visible light beam, preferably at a heat less than
- a further embodiment is a method of treating a tooth by changing the structure and composition of the tooth to decrease the amount of carbonate in said tooth by irradiating said tooth with a visible or near visible light beam.
- the structure is changed at a heat less than 250°C.
- DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention describes a method which changes the solubility of a tooth without significant production of heat, in fact the present invention produces changes in the tooth at temperatures less than 250°C.
- the present invention also allows for a deeper treatment of the tooth, as well as the use of a lower concentration of fluoride, and has the potential to allow one to keep teeth completely free of caries for the lifetime of the patient.
- the method uses a visible light beam (or electromagnetic radiation) alone or in combination with a chemical agent to prevent dental caries.
- a visible light beam or electromagnetic radiation
- a chemical agent to prevent dental caries.
- the application of the visible light beam of the correct wavelength, (i.e. an argon laser beam) at low powers to the tooth acts on the "thermal sites" at a much reduced temperature (usually around 100°C) and produces considerably less heat then CO or comparable lasers.
- the visible light beam reduces the carbonated phase of the hydroxyapatite, making the tooth more resistant to attack.
- the removal or vaporization of carbonate lowers the solubility and changes the water content of the hydroxyapatite. It also changes the phase of the hydroxyapatite and makes it more pure.
- the treatment may heat local sites in proximity to the surface, which have a high concentration of organic material and/or water.
- the ratio of phosphate to calcium changes. All of these changes result in the increased capability of the tooth to resist demineralization, a precursor to tooth decay.
- Fluoridation, or other chemical agents act on the "chemical sites" by binding to hydroxide radicals and sterically or chemically preventing the action of acid on those sites.
- fluoride can accumulate in the body and too much fluoride can result in fluorosis, a syndrome whereby teeth are discolored, resulting in white splotchy areas on the enamel during development.
- Children are particularly susceptible to fluorosis and can obtain the necessary concentration of fluoride simply from tap water and toothpaste which is accidentally swallowed during brushing, hi addition, more serious diseases have been linked to too much fluoride including iodine deficiency disorders, confusion, drowsiness, and listlessness.
- the laser treatment results in a situation in which less fluoride is necessary to provide the same result.
- the visible and near visible light beams can be coherent or incoherent light sources.
- Lasers, coherent sources of light beams, useful in the present invention are those which generate sufficient power to increase the acid resistivity of tooth enamel at low power (producing less heat) which preferably fall within the visible part of the infrared.
- the lasers possess one or more wavelengths which are not absorbed by water, but are absorbed by organic compounds.
- the wavelengths are between about 400 and 810 nm, more preferably between about 457 and 514 nm.
- the wavelengths correspond visibly to blue, green, yellow or red light. Examples of such lasers include argon lasers and diode lasers.
- the visible light beams can be incoherent sources which generate sufficient power to increase the acid resistivity of tooth enamel at low power (producing less heat), such as a light emitting diodes (LEDs).
- LEDs light emitting diodes
- the wavelengths are between about 400 and 810 nm, more preferably between about 457 and 514 nm.
- the wavelengths correspond visibly to blue, green, yellow or red.
- the lasers need only be used at low power to produce the desired effect.
- the light beam has an energy density below about 65 J/cm 2 , preferably about 30 J/cm 2 , preferably an energy density below about 12 J/cm 2 .
- the chemical agents may have very different mechanisms of action, but include: ethane- l-hydroxy-l,l-di- ⁇ hosphonic acid, fluoride, dodecylamine HC1, and most preferably fluoride.
- fluoride treatments can be used alone or in combination.
- the fluoride can be applied as a paste before treatment with the laser or after treatment with the laser.
- the fluoride can be applied as a mouthwash or as part of a toothpaste.
- the fluoride may also be applied as a patch, providing a low concentration of fluoride in a timed-release manner.
- mucoadhesive fluoride tablets consisting of a bioerodible matrix which dissolves completely after depletion can be used such as those described in Bottenberg et al. J Dent. Res. 77(1): 68-72.
- Fluoride (F1-) interacts at several stages of the caries process to inhibit progression or enhance reversal.
- the following three mechanisms of action are now considered to be the most important way in which fluoride works.
- fluoride has antibacterial properties at lower pH in the plaque when it enters the bacterial cell as HF1.
- fluoride enters the bacteria it interferes with the enzymes inside the bacteria, slowing down or inhibiting acid production.
- fluoride when fluoride is present in the aqueous phase on and within the tooth at the same time as an acid challenge, it dramatically inhibits dissolution of calcium and phosphate at the crystal surfaces in the subsurface regions of enamel.
- fluoride is present in the tooth crystals where it is incorporated systematically during tooth development, it will dissolve out during the demineralization process and help to inhibit subsequent demineralization. Lastly, fluoride present in the aqueous phase at the crystal surfaces within the tooth speeds up the recrystallization by helping to bring calcium and phosphate ions together. This provides a much more acid-resistant "new" crystal surface. During subsequent acid challenges following ingestion of fermentable carbohydrates the acid bypasses this resistant mineral, and is forced to go deeper into the tooth before mineral can be dissolved making decay less and less likely to progress. Remineralization following demineralization in this way makes the tooth more and more resistant as time progresses with these natural pH-cycles.
- Example 1 shows for the first time in the literature that the a axis of hydroxyapatite can be changed by treatment with a laser at low heat.
- Enamel from 47 human teeth were subjected to treatment with an argon laser at various energy densities ranging from 65 to 283 J/cm 2 for 0.2 sec at 1 Hz.
- the enamel was then subjected to x-ray diffraction.
- Results from this treatment showed that there was a mechanical change in the a axis of the human enamel (HE) from 9.45 A to 9.43 A (see Table 1). Such a reduction was statistically significant. It is known in the literature that the hydroxyapatite of human enamel is more soluble than stoichiometric hydroxyapatite, which has an a axis of 9.418 A approaching that of lased enamel.
- This axis reduction is caused by a loss of structural water and a corresponding increase in structural hydroxide groups (OH-) along the a axis.
- Another causative factor is the vaporization of organic compounds such as carbonate which results in a prism structure with reduced voids where acids would preferentially attack when the tooth is exposed to acids in the saliva.
- enamel from 7 human teeth was subjected to treatment with an argon laser at various energy densities ranging from 65 to 283 J/cm 2 for 0.2 sec at 1 Hz.
- Laser treatment in combination with fluoride treatment results in the removal of organic compounds and a hardening of the hydroxyapatite crystal at a deeper level
- Enamel from human teeth is treated with a fluoride paste at a concentration of 200 ppm (0.08%) Fl of stannous fluoride.
- the treated enamel is then subjected to treatment with an argon laser at 12-30 J/cm 2 for 10 seconds for each treated surface.
- Treatment efficacy is compared to enamel treated with fluoride alone or argon laser alone.
- the argon laser is safer and still penetrates more deeply due to its lower absorption, vaporization of the organic molecules including carbonate and hydrolyzation of the HPO 4 molecule.
- the removal of H+ at the surface as well as below the surface and the removal of water within the tooth structure allows for the bonding of fluoride at deeper levels of the hydroxyapatite.
- the present method provides for the bonding of fluoride to the hydroxide molecule in decreasing concentrations as one descends from the surface of the enamel towards the pulp, providing a much deeper effect on the tooth (to at least 1 mm).
- Enamel from a human tooth is treated with a fluoride paste at a concentration of 200 ppm (0.08%) Fl of stannous fluoride or 1000 ppm (0.22%) Fl of sodium fluoride.
- the treated enamel is then subjected to treatment with an argon laser at 12-65 J/cm for 0.2 to 10 seconds for each treated surface.
- the treatment effectiveness is compared to a comparable treatment using much higher (5-fold) concentrations of fluoride.
- Previous results using a CO 2 laser have shown that the amount of fluoride applied to the tooth after laser treatment can be reduced by about five-fold for an effective treatment. Therefore, the effective concentration of fluoride applied before or after laser treatment is reduced approximately five fold in the present method.
- Example 1 When the laser treatment as presented in Example 1 is used in combination with the fluoride treatment a synergistic effect occurred and this was partly responsible for the need for less fluoride. This is shown by the fact that the results in Examples 3 and 4 with both fluoride and argon laser treatment are more then additive when compared to those with fluoride alone or laser treatment alone.
- Enamel from 4 human teeth is treated with a fluoride paste at a concentration of 200 ppm (0.08%) Fl of stannous fluoride or 1000 ppm (0.22%) Fl of sodium fluoride.
- the treated enamel is then subjected to treatment with an argon laser at 250 MW, 10 Hz for 0.2 to 10 seconds for each treated surface. Three measurements were per tooth and the mean value is shown below.
- the two-tailed p value is 0,0320; Significant
- Mean A unlased enamel
- Mean C Enamel + fluoride + lased
- the two tailed p value is 0.0408; Significant
- the Argon laser is applied to the tooth at 250 mW (or 12 to 65 J/cm 2 ) for 0.2 to 10 sec at a 5 mm diameter spot size on the tooth surfaces.
- the teeth Prior to lasing, the teeth were prophied (cleaned) and a low concentration of fluoride gel was applied.
- the fluoride gel may be applied after laser treatment.
- Maintenance treatment includes using a fluoride mouthwash containing low concentrations of fluoride once a day, and fluoride patches containing low concentrations of fluoride applied weekly.
- the teeth are laser treated every 2 to 5 years.
- EXAMPLE 8 Method of treating a tooth using a visible LED
- the tooth is treated as in Example 6, however an LED is used in place of the argon laser.
- the LED is used at a wavelength from the IR spectra of green, blue, yellow, or red.
- the tooth is treated with fluoride at a concentration of about 200 ppm (0.08%) Fl of stannous fluoride or 1000 ppm (0.22%) Fl of sodium fluoride.
- the Argon laser is applied to the tooth at 250 to 300 mW for 10 sec (or longer) at an 8 mm diameter spot size on each of the surfaces.
- the teeth Prior to lasing, the teeth were prophied (cleaned) and a low concentration of fluoride gel was applied.
- Maintenance treatment includes using a fluoride mouthwash containing low concentrations of fluoride once a day, and fluoride patches containing low concentrations of fluoride applied weekly.
- the teeth are laser treated every 2 to 5 years.
- EXAMPLE 10 Kit for at-home use The kit includes a hand-held light source, LED with a shield which protects the patient from laser reflections which may damage their eyes, while still allowing viewing of the process, a fluoride treatment for application to the tooth before laser treatment, a mouthwash with a low fluoride concentration, and patches with a low fluoride concentration for follow-up use.
- the patient applies the fluoride, treats the tooth with the laser, uses the mouthwash daily, and attaches the patch once a week or once a month. This allows the patient to keep the teeth caries-free as long as treatment is continued. However, treatment may still be effective without the addition of the mouthwash or the patch.
- EXAMPLE 11 Kit for professional use The kit includes a hand-held light source, LED with a shield which protects the patient from laser reflections which may damage their eyes, while still allowing viewing of the process, a fluoride treatment for application to the tooth before laser treatment, a mouthwash with a low fluoride concentration, and patches with
- the kit includes a fluoride treatment containing a low concentration of fluoride, a means for applying the fluoride to the tooth, sample mouthwash and sample patches for the patient to take home.
- a fluoride treatment containing a low concentration of fluoride
- a means for applying the fluoride to the tooth sample mouthwash and sample patches for the patient to take home.
- Various types of light sources can be used by the professional.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002248294A AU2002248294A1 (en) | 2002-01-04 | 2002-01-04 | Method and apparatus for preventing tooth decay |
PCT/US2002/000084 WO2003059305A1 (fr) | 2002-01-04 | 2002-01-04 | Procede et dispositif pour la prevention de la carie dentaire |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/000084 WO2003059305A1 (fr) | 2002-01-04 | 2002-01-04 | Procede et dispositif pour la prevention de la carie dentaire |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003059305A1 true WO2003059305A1 (fr) | 2003-07-24 |
Family
ID=21743189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/000084 WO2003059305A1 (fr) | 2002-01-04 | 2002-01-04 | Procede et dispositif pour la prevention de la carie dentaire |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002248294A1 (fr) |
WO (1) | WO2003059305A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7845039B2 (en) | 2003-09-09 | 2010-12-07 | The Procter & Gamble Company | Toothbrush with severable electrical connections |
EP2873388A1 (fr) * | 2013-11-19 | 2015-05-20 | Sirona Dental Systems GmbH | Chirurgie laser de tissus mous |
US11529214B2 (en) | 2017-05-12 | 2022-12-20 | Convergent Dental, Inc. | System and methods for preventative dental hard tissue treatment with a laser |
US11918824B2 (en) | 2020-01-03 | 2024-03-05 | Convergent Dental, Inc. | Laser system for enhancing remineralization and strength of hard tissue |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732617A (en) * | 1982-08-24 | 1988-03-22 | National Research Development Corporation | Fluoride-containing compositions |
US4877401A (en) * | 1988-03-09 | 1989-10-31 | University Of Utah | Method of preventing tooth decay by laser beam irradiation and chemical treatment |
US5145667A (en) * | 1990-03-29 | 1992-09-08 | Beecham Inc. | Compositions |
US5616141A (en) * | 1993-04-09 | 1997-04-01 | Ion Laser Technology | Laser system for use in dental procedures |
WO2000067048A2 (fr) * | 1999-05-03 | 2000-11-09 | Premier Laser Systems, Inc. | Source optique et procede |
-
2002
- 2002-01-04 AU AU2002248294A patent/AU2002248294A1/en not_active Abandoned
- 2002-01-04 WO PCT/US2002/000084 patent/WO2003059305A1/fr not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732617A (en) * | 1982-08-24 | 1988-03-22 | National Research Development Corporation | Fluoride-containing compositions |
US4877401A (en) * | 1988-03-09 | 1989-10-31 | University Of Utah | Method of preventing tooth decay by laser beam irradiation and chemical treatment |
US5145667A (en) * | 1990-03-29 | 1992-09-08 | Beecham Inc. | Compositions |
US5616141A (en) * | 1993-04-09 | 1997-04-01 | Ion Laser Technology | Laser system for use in dental procedures |
WO2000067048A2 (fr) * | 1999-05-03 | 2000-11-09 | Premier Laser Systems, Inc. | Source optique et procede |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7845039B2 (en) | 2003-09-09 | 2010-12-07 | The Procter & Gamble Company | Toothbrush with severable electrical connections |
EP2873388A1 (fr) * | 2013-11-19 | 2015-05-20 | Sirona Dental Systems GmbH | Chirurgie laser de tissus mous |
US11529214B2 (en) | 2017-05-12 | 2022-12-20 | Convergent Dental, Inc. | System and methods for preventative dental hard tissue treatment with a laser |
US11744671B2 (en) | 2017-05-12 | 2023-09-05 | Convergent Dental, Inc. | System and methods for preventative dental hard tissue treatment with a laser |
US11918824B2 (en) | 2020-01-03 | 2024-03-05 | Convergent Dental, Inc. | Laser system for enhancing remineralization and strength of hard tissue |
US12233278B2 (en) | 2020-01-03 | 2025-02-25 | Convergent Dental, Inc. | Laser system for enhancing remineralization and strength of hard tissue |
Also Published As
Publication number | Publication date |
---|---|
AU2002248294A1 (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7163400B2 (en) | Method and laser apparatus for preventing tooth decay | |
Hsu et al. | Laser-matrix-fluoride effects on enamel demineralization | |
Zezell et al. | Nd: YAG laser in caries prevention: a clinical trial | |
EP1951184B1 (fr) | Procédés et compositions pour le blanchiment des dents | |
EP0814756B1 (fr) | Procede d'elaboration d'une preparation de blanchiment des dents ou de traitement de symptomes cutanes et de troubles des muqueuses | |
US20070237728A1 (en) | Method and Composition for Dental Bleaching | |
Steiner-Oliveira et al. | Effect of the CO2 laser combined with fluoridated products on the inhibition of enamel demineralization | |
Huang et al. | Synergistic effect of Nd: YAG laser combined with fluoride varnish on inhibition of caries formation in dental pits and fissures in vitro. | |
AU2000272625A1 (en) | Method and composition for dental bleaching | |
Araujo et al. | Effect of pH values of two bleaching gels on enamel microhardness | |
US6939535B2 (en) | Method and apparatus for preventing tooth decay | |
Sanavia et al. | Remineralization strategies in oral hygiene: a position paper of Italian society of oral hygiene sciences-SISIO Working group | |
WO2003059305A1 (fr) | Procede et dispositif pour la prevention de la carie dentaire | |
WO2009133525A2 (fr) | Composition pour blanchiment des dents | |
Malik et al. | Effect of laser and fluoride application for prevention of dental caries: A polarized microscope analysis | |
KR20080050590A (ko) | 치아 표백재 및 치아 표백 방법 | |
Zanin et al. | Dental bleaching with LEDs and lasers | |
Baid et al. | Comparison of effectiveness of diode laser with er: YAG laser on fluoride uptake of enamel surface using acidic and neutral topical fluorides: an in-vitro study | |
dos Santos et al. | Effect of a new carbon dioxide laser and fluoride on occlusal caries progression in dental enamel | |
Sharma | Biomodification of tooth discolouration | |
Walsh | Strategies for remineralization | |
Hashim et al. | Alterations In Enamel Minerals Occur On Remineralizing Artificially Created White Spot Lesions Subjected To Either Chemical Or Laser-Assisted Bleaching. | |
WO2023159244A3 (fr) | Traitement et prévention de la déminéralisation dentaire | |
Almarsomy et al. | Differnts Effectiveness of 10,600 nm Carbon Dioxide Laser on Enamel Surface | |
Fekrazad et al. | The role of laser in caries prevention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |